APA

Babaian R. J., Johnston D. A., Naccarato W., Ayala A., Bhadkamkar V. A. & Fritsche HA H. A. (20010503). The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy. : The Journal of urology.

Chicago

Babaian R J, Johnston D A, Naccarato W, Ayala A, Bhadkamkar V A and Fritsche HA H A. 20010503. The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy. : The Journal of urology.

Harvard

Babaian R. J., Johnston D. A., Naccarato W., Ayala A., Bhadkamkar V. A. and Fritsche HA H. A. (20010503). The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy. : The Journal of urology.

MLA

Babaian R J, Johnston D A, Naccarato W, Ayala A, Bhadkamkar V A and Fritsche HA H A. The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy. : The Journal of urology. 20010503.